| pubmed-article:16029343 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:16029343 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:16029343 | lifeskim:mentions | umls-concept:C0013072 | lld:lifeskim |
| pubmed-article:16029343 | lifeskim:mentions | umls-concept:C0034656 | lld:lifeskim |
| pubmed-article:16029343 | lifeskim:mentions | umls-concept:C0042900 | lld:lifeskim |
| pubmed-article:16029343 | lifeskim:mentions | umls-concept:C0023556 | lld:lifeskim |
| pubmed-article:16029343 | lifeskim:mentions | umls-concept:C0439801 | lld:lifeskim |
| pubmed-article:16029343 | lifeskim:mentions | umls-concept:C0332261 | lld:lifeskim |
| pubmed-article:16029343 | lifeskim:mentions | umls-concept:C0439834 | lld:lifeskim |
| pubmed-article:16029343 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:16029343 | pubmed:dateCreated | 2005-7-20 | lld:pubmed |
| pubmed-article:16029343 | pubmed:abstractText | A previous uncontrolled, open trial of levamisole in patients with limited and slowly spreading vitiligo had shown that new lesions did not develop in 94% of patients after 2-4 months of treatment with the drug. | lld:pubmed |
| pubmed-article:16029343 | pubmed:language | eng | lld:pubmed |
| pubmed-article:16029343 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16029343 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:16029343 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16029343 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16029343 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:16029343 | pubmed:month | Jul | lld:pubmed |
| pubmed-article:16029343 | pubmed:issn | 0007-0963 | lld:pubmed |
| pubmed-article:16029343 | pubmed:author | pubmed-author:AgarwalSS | lld:pubmed |
| pubmed-article:16029343 | pubmed:author | pubmed-author:SharmaV KVK | lld:pubmed |
| pubmed-article:16029343 | pubmed:author | pubmed-author:RamanLL | lld:pubmed |
| pubmed-article:16029343 | pubmed:author | pubmed-author:PanNN | lld:pubmed |
| pubmed-article:16029343 | pubmed:author | pubmed-author:PandeyR MRM | lld:pubmed |
| pubmed-article:16029343 | pubmed:author | pubmed-author:KhandpurSS | lld:pubmed |
| pubmed-article:16029343 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:16029343 | pubmed:volume | 153 | lld:pubmed |
| pubmed-article:16029343 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:16029343 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:16029343 | pubmed:pagination | 163-6 | lld:pubmed |
| pubmed-article:16029343 | pubmed:meshHeading | pubmed-meshheading:16029343... | lld:pubmed |
| pubmed-article:16029343 | pubmed:meshHeading | pubmed-meshheading:16029343... | lld:pubmed |
| pubmed-article:16029343 | pubmed:meshHeading | pubmed-meshheading:16029343... | lld:pubmed |
| pubmed-article:16029343 | pubmed:meshHeading | pubmed-meshheading:16029343... | lld:pubmed |
| pubmed-article:16029343 | pubmed:meshHeading | pubmed-meshheading:16029343... | lld:pubmed |
| pubmed-article:16029343 | pubmed:meshHeading | pubmed-meshheading:16029343... | lld:pubmed |
| pubmed-article:16029343 | pubmed:meshHeading | pubmed-meshheading:16029343... | lld:pubmed |
| pubmed-article:16029343 | pubmed:meshHeading | pubmed-meshheading:16029343... | lld:pubmed |
| pubmed-article:16029343 | pubmed:meshHeading | pubmed-meshheading:16029343... | lld:pubmed |
| pubmed-article:16029343 | pubmed:meshHeading | pubmed-meshheading:16029343... | lld:pubmed |
| pubmed-article:16029343 | pubmed:meshHeading | pubmed-meshheading:16029343... | lld:pubmed |
| pubmed-article:16029343 | pubmed:meshHeading | pubmed-meshheading:16029343... | lld:pubmed |
| pubmed-article:16029343 | pubmed:meshHeading | pubmed-meshheading:16029343... | lld:pubmed |
| pubmed-article:16029343 | pubmed:meshHeading | pubmed-meshheading:16029343... | lld:pubmed |
| pubmed-article:16029343 | pubmed:year | 2005 | lld:pubmed |
| pubmed-article:16029343 | pubmed:articleTitle | A randomized placebo-controlled double-blind study of levamisole in the treatment of limited and slowly spreading vitiligo. | lld:pubmed |
| pubmed-article:16029343 | pubmed:affiliation | Department of Psychiatry, All India Institute of Medical Sciences, New Delhi 110 029, India. | lld:pubmed |
| pubmed-article:16029343 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:16029343 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:16029343 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16029343 | lld:pubmed |
